OÜ VMNGroup

Active Registry code 14696583 OÜ Tallinn Registered 3 Apr 2019
Compare

OÜ VMNGroup is a OÜ based in Tallinn, registry code 14696583, status: active. Main activity: Manufacture of basic pharmaceutical products. Its annual report for 2024 shows revenue of €0 and 0 employees.

Revenue
0 €
Employees
0
±0 vs 2023

2024 · annual report, e-Äriregister

Position in the industry Manufacture of basic pharmaceutical products and pharmaceutical preparations · EMTAK 21

  • Revenue · 2024 0 €
    industry median 25 284 € · companies in the industry: 24

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2019 – 2024
Revenue, € 2024: 0 € · industry median 25 284 € · above 5% of the industry
010 00020 00030 0002019 Company: 0 € Industry median: 28 809 €20192020 Company: 0 € Industry median: 25 207 €20202021 Company: 0 € Industry median: 11 877 €20212022 Company: 0 € Industry median: 4 897 €20222023 Company: 0 € Industry median: 3 851 €20232024 Company: 0 € Industry median: 25 284 €2024010 00020 00030 0002019 Company: 0 € Industry median: 28 809 €2020 Company: 0 € Industry median: 25 207 €20202021 Company: 0 € Industry median: 11 877 €2022 Company: 0 € Industry median: 4 897 €20222023 Company: 0 € Industry median: 3 851 €2024 Company: 0 € Industry median: 25 284 €2024
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2024: 0 € · industry median 0 € · above 45% of the industry
01 0002 0003 0002019 Company: 0 € Industry median: 2 812 €20192020 Company: 0 € Industry median: 97 €20202021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 0 €20222023 Company: 0 € Industry median: 0 €20232024 Company: 0 € Industry median: 0 €202401 0002 0003 0002019 Company: 0 € Industry median: 2 812 €2020 Company: 0 € Industry median: 97 €20202021 Company: 0 € Industry median: 0 €2022 Company: 0 € Industry median: 0 €20222023 Company: 0 € Industry median: 0 €2024 Company: 0 € Industry median: 0 €2024
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2024: 2 500 € · +0.0% vs 2023
05001 0001 5002 0002 5002019 Company: 0 €20192020 Company: —20202021 Company: —20212022 Company: —20222023 Company: 2 500 €20232024 Company: 2 500 €202405001 0001 5002 0002 5002019 Company: 0 €2020 Company: —20202021 Company: —2022 Company: —20222023 Company: 2 500 €2024 Company: 2 500 €2024
Equity, € 2024: 2 500 € · +0.0% vs 2023
05001 0001 5002 0002 5002019 Company: —20192020 Company: —20202021 Company: —20212022 Company: —20222023 Company: 2 500 €20232024 Company: 2 500 €202405001 0001 5002 0002 5002019 Company: —2020 Company: —20202021 Company: —2022 Company: —20222023 Company: 2 500 €2024 Company: 2 500 €2024
Employees 2024: 0 · industry median 32 · above 2% of the industry
0102030402019 Company: 0 Industry median: 3420192020 Company: 0 Industry median: 32.520202021 Company: 0 Industry median: —20212022 Company: 0 Industry median: —20222023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 3220240102030402019 Company: 0 Industry median: 342020 Company: 0 Industry median: 32.520202021 Company: 0 Industry median: —2022 Company: 0 Industry median: —20222023 Company: 0 Industry median: 252024 Company: 0 Industry median: 322024
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2024 0 0 0 2 500 2 500 0
2023 0 0 0 2 500 2 500 0
2022 0 0 0 — — 0
2021 0 0 0 — — 0
2020 0 0 0 — — 0
2019 0 0 0 0 — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2024

Return on equity (ROE)
0.0 %
Net profit / equity
Return on assets (ROA)
0.0 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2024 1 Jan 2024 – 31 Dec 2024 27 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 1 Jul 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 9 Nov 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 9 Nov 2023 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 9 Nov 2023 Company’s own e-Äriregister
2019 3 Apr 2019 – 31 Dec 2019 9 Nov 2023 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 21101Manufacture of basic pharmaceutical products Main
Rulings
Number, date Title Deadline State Document
Ä 50116644 / 5
7 Aug 2026
Amendment entry In force
7 Aug 2026
PDF
Ä 50116644 / 4
25 Jun 2024
Amendment entry In force
25 Jun 2024
PDF
Ä 50116644 / 3
7 Jun 2024
Amendment entry In force
7 Jun 2024
PDF
Ä 50116644 / 2
2 Sep 2023
Amendment entry In force
2 Sep 2023
PDF
Ä 50116644 / M4
30 Dec 2022
Public service of a ruling in Ametlikud Teadaanded In force
30 Dec 2022
PDF
Ä 50116644 / M3
8 Apr 2022
Fine for not filing the report 30 Jan 2023 In force
31 Jan 2023
PDF
Ä 50116644 / M2
8 Feb 2022
Warning of a fine: annual report not filed 10 Mar 2022 In force
8 Feb 2022
PDF
Ä 50116644 / M1
3 Apr 2019
Ruling to eliminate deficiencies 18 Apr 2019 Deficiencies eliminated
3 Apr 2019
PDF
Ä 50116644
3 Apr 2019
First entry In force
3 Apr 2019
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data